Showing results (1-10 of 752) with videos related to
Sort By:
Pageof 76
Arthritis and Rheumatism|June 10, 2003
Predicting mortality in patients with rheumatoid arthritisFrederick Wolfe, Kaleb Michaud, Olaf Gefeller, et al.Arthritis and Rheumatism|October 15, 2003
Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patientsKaleb Michaud, Jodi Messer, Hyon K Choi, et al.The Journal of Rheumatology|October 6, 2005
Household income and earnings losses among 6,396 persons with rheumatoid arthritisFrederick Wolfe, Kaleb Michaud, Hyon K Choi, et al.Arthritis and Rheumatism|June 10, 2004
Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patientsFrederick Wolfe, Kaleb MichaudArthritis and Rheumatism|May 1, 2009
Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidityFrederick Wolfe, Kaleb MichaudRheumatology (Oxford, England)|June 23, 2010
The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bankFrederick Wolfe, Kaleb MichaudBest Practice & Research. Clinical Rheumatology|September 18, 2007
Comorbidities in rheumatoid arthritisKaleb Michaud, Frederick WolfeArthritis Care & Research|April 20, 2012
Effect of body mass index on mortality and clinical status in rheumatoid arthritisFrederick Wolfe, Kaleb MichaudArthritis and Rheumatism|June 30, 2007
Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choicesFrederick Wolfe, Kaleb MichaudThe Journal of Rheumatology|July 6, 2007
Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapyFrederick Wolfe, Kaleb MichaudPageof 76